Metronidazole Noridem (Metronidazole)

Metronidazole is reduced inside anaerobic microorganisms to form reactive nitro radicals. These radicals bind to DNA, causing strand breakage and inhibiting nucleic acid synthesis, which ultimately leads to microbial cell death while sparing aerobic human cells.

The dosage of Metronidazole Noridem is determined by the prescribing clinician based on the specific infection, patient weight, renal and hepatic function, and treatment guidelines. Only a qualified health professional should set the dosing regimen.

The safety of Metronidazole Noridem in pregnancy has not been definitively established. It should be used only if the potential benefit justifies any potential risk to the fetus. Breastfeeding mothers should consult their physician, as the drug may be excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metronidazole is a nitroimidazole that specifically targets anaerobic bacteria and certain protozoa, offering rapid bactericidal activity. Compared with broad‑spectrum agents like clindamycin, it has a narrower spectrum focused on anaerobes, often resulting in fewer disturbances to normal flora.

Metronidazole Noridem should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from direct sunlight, moisture, and extreme temperature fluctuations to maintain stability.

Metronidazole Noridem is supplied as an injectable solution for intravenous infusion. It is administered by a qualified healthcare professional, typically diluted in compatible IV fluids and infused over a prescribed period.

Serious risks include seizures, peripheral neuropathy, and severe allergic reactions such as anaphylaxis. Patients should be monitored for neurological symptoms, skin reactions, and any signs of hypersensitivity, and treatment should be discontinued if these occur.

Metronidazole Noridem is contraindicated in patients with a known hypersensitivity to metronidazole or other nitroimidazoles. It should also be avoided in individuals receiving concurrent metronidazole therapy or those with severe hepatic impairment unless specifically directed by a physician.